324 related articles for article (PubMed ID: 27778118)
1. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
[TBL] [Abstract][Full Text] [Related]
2. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.
Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S
Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a panel of tumor-associated antigens in breast cancer.
Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
5. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
[TBL] [Abstract][Full Text] [Related]
6. FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer.
Xu S; Huangfu M; Jia X; Song X; Sun B; Lee KH; Liu L; Sun S
Int J Clin Oncol; 2015 Oct; 20(5):982-8. PubMed ID: 25681877
[TBL] [Abstract][Full Text] [Related]
7. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
[TBL] [Abstract][Full Text] [Related]
9. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
Evans RL; Pottala JV; Egland KA
Cancer Prev Res (Phila); 2014 May; 7(5):545-55. PubMed ID: 24641868
[TBL] [Abstract][Full Text] [Related]
10. Detecting of p16 Autoantibody as a Potential Early Diagnostic Serum Biomarker in Patients with Cervical Cancer.
Huangfu M; Liu L; Xu S; Li S; Jiang K; Sun B; Lee KH; Sun S
Clin Lab; 2016; 62(6):1117-20. PubMed ID: 27468574
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
Liu W; De La Torre IG; Gutiérrez-Rivera MC; Wang B; Liu Y; Dai L; Qian W; Zhang JY
Tumour Biol; 2015 Feb; 36(2):1307-12. PubMed ID: 25355596
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of the Survivin Autoantibody in Four Types of Malignancies.
Xiu Y; Sun B; Jiang Y; Wang A; Liu L; Liu Y; Sun S; Huangfu M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):384-389. PubMed ID: 29924656
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
15. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality.
Evans RL; Pottala JV; Nagata S; Egland KA
BMC Cancer; 2018 Jan; 18(1):119. PubMed ID: 29386014
[TBL] [Abstract][Full Text] [Related]
17. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.
Liu X; Chai Y; Li J; Ren P; Liu M; Dai L; Qian W; Li W; Zhang JY
Tumour Biol; 2014 Mar; 35(3):2661-7. PubMed ID: 24399648
[TBL] [Abstract][Full Text] [Related]
19. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
[TBL] [Abstract][Full Text] [Related]
20. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]